APPLICATIONS PUBLISHED 7 MAY 2003
Published: 1-Nov-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
A method of preparing a pharmaceutical compsn
Psiron 1307180*
Novel combinations of minoxidil
Pharmacia 1307181*
Pharmaceutical compsn for transdermal delivery of befloxatone
Sanofi-Synthelabo 1307182*
Treatment of the insulin resistance syndrome with selective CGMP PDE5 inhibitors
Pfizer 1307183*
Drugs for incontinence
Nicox 1307184*
Method for the prevention and treatment of retinopathy
Stefansson, Einar 1307185*
Methods for decreasing cell proliferation based on (3R, 4R)-delta-8-tetrahydrocannabinol-11-oic acids
Atlantic Technology Ventures 1307186*
Use of 13-cis retinoic acid for the treatment of emphysema
F Hoffmann-la Roche 1307187*
Cannabinoid drugs
Atlantic Technology Ventures; Recht, Lawrence; Zurier, Robert 1307188*
Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
Immunapharm 1307189*
Use of IL-8 receptor antagonists in the treatment of virus infections
SmithKline Beecham 1307190*
Use of indole derivatives for the manufacture of a medicament for reducing intracellular pressure
Inspire Pharmaceuticals; University Complutense de Madrid 1307191*
New use of angiotensin II antagonists
AstraZeneca 1307192*
Agonists of follicle stimulating hormone activity
Affymax Research Institute 1307193*
Fentanyl compsn for nasal administration
Nycomed Danmark 1307194*
Medicaments containing cilansetron for treating non-obstipated male IBS patients
Solvay Pharmaceuticals 1307195*
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
North Shore-Long Island Jewish Research Institute 1307196*
Compsns for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide
Celgene 1307197*
Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase
Hanwha Chemical 1307198*
Pharmaceutical compsns of anti-tubercular drugs and process for their preparation
Panacea Biotec 1307199*
Substituted triazolopyrimidines as anticancer agents
Wyeth 1307200*
Selective PDE 2 inhibitors, used as medicaments for improving cognition
Bayer 1307201*
Method for the treatment of overactive bladder
AstraZeneca 1307202*
Protease inhibitors
SmithKline Beecham 1307203*
Protease inhibitors
SmithKline Beecham 1307204*
Use of 7-alpha-hydroxy-estradiol, 7-alpha-hydroxy-dehydroepiandrosterone and 7-alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration
BTG International 1307205*
Method for enhancing bone mineral density gain by administration of raloxifen
Eli Lilly 1307206*
Extended type 1 chain glycosphingolipids as tumour-associated antigens
The Biomembrane Institute 1307207*
Use of CO for treating inflammation of upper airways or bronchi
L'Air Liquide Sante (International) 1307208*
Cardioplegic solution
Jolife 1307209*
Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares
Solvay Pharmaceuticals 1307210*
Immune mediators and related methods
Corixa 1307211*
Plant-derived antioxidants
World Resources Corp 1307212*
Chlorella preparations exhibiting immunomodulating properties
Ocean Nutrition Canada 1307213*
Highly homogeneous molecular markers for electrophoresis
Invitrogen 1307214*
I-superfamily conotoxins
The University of Utah Research Foundations 1307215*
Polymer-modified bioactive synthetic chemokines, and methods for the manufacture and use
Gryphon Therapeutics 1307216*
VIP-related peptides for the treatment of skin disorders
Yeda Research and Development; Ramot University Authority for Applied Research and Industrial Development; The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1307217*
Obesity controlling method
Temple University of the Commonwealth System of Higher Education 1307218*
Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
The Trustees of Columbia University in the City of New York 1307219*
Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
Aronex Pharmaceuticals 1307220*
Modified salicylic acid vaccines
National Research Council of Canada 1307221*
Non-human animal models of tolerance to hepatitis C virus immunogens
Chiron 1307222*
Parenteral vaccine formulations and uses thereof
Alk-Abello 1307223*
Vaccines comprising outer membrane vesicles from gram negative bacteria
GlaxoSmithKline Biologicals 1307224*
Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
Immunex Corp 1307225*
Vitronectin receptor antagonist pharmaceuticals
Bristol-Myers Squibb Pharma 1307226*
Pharmaceutical compsns
Novartis 1307227*
Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
Chemocentryx 1307228*
Combination preparation with an er-beta selective oestrogen and a serm or antiestrogen
Schering 1307229*
Enhancement of development of oviparous species by in ovo feeding
North Carolina State University; Yissum Research Development of the Hebrew University of Jerusalem 1307230*
Transdermal drug delivery system
Ben Gurion Authority of the Negev Research and Development Authority; Shintov, Amnon; Gorodischer, Raphael 1307231*
Novel compsn for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
Antares Pharma 1307232*
Therapeutic polyanhydride compounds for drug delivery
Rutgers, The State University 1307233*
